Good posts today on vaccines. Yes, the Pfizer study elicited slightly greater antibody immune responses at significantly lower vaccine doses. The Pfizer/BioNTech mRNA vaccine, in phase I ishowed that those who received 30 micrograms of the vaccine candidate generated antibodies that were 2.8 times higher than the average of a group of patients who had confirmed prior infections (267 geometric mean titers in vaccine recipients vs. 94 in recovered patients), whereas the Moderna vaccine produced a ratio of 2.2 to 1 in geometric mean titers at a 100 mcg dose (3.3X the dose of the Pfizer vaccine).
Having said that, I doubt these differences are more than minor at the phase I stage (with very small numbers of patients, i.e., <50, vs. the 20-30K or more planned for the large phase III trials) with the take home message for both mRNA vaccine candidates being that both elicited strong immune responses at reasonable doses, with minimal side effects. This is essentially what Dr. Fauci said earlier today, quoted in the article you linked.
Asked to compare the Moderna and Pfizer vaccine data, Fauci said, “I don’t think you could say anything about one being better than the other. They both induce good responses. Let’s see what happens in the real world.”
Dr. Fauci also said the comments below about the Moderna vaccine. He had similar comments about the Pfizer vaccine and the bottom line is that it's great there were no red flags in either vaccine so far, but as many have pointed out, there's a long, long way to go from phase I results to having a commercially available vaccine - but it's a good start and way better than if the phase I results had failed.
https://uk.advfn.com/stock-market/l...vid-19-Vaccine-Moves-to-Bigger-Study/82854799
"This is really quite good news," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said in an interview Tuesday. NIAID co-developed the Moderna vaccine and led the study.
"The gold standard of protection against a viral infection is neutralizing antibodies," he added. "And the data from the study, small numbers as it may be, are pretty clear that this vaccine is capable of inducing quite good [levels] of neutralizing antibodies."
Fauci still thinks it's possible we'll have a vaccine by the end of the year, as do I, notwithstanding Merck CEO Ken Frazier's comments, as posted by @TroothSkr. Having worked at Merck for over 30 years, Ken and Merck are simply very conservative on overpromising and underdelivering, so his comments do not surprise me at all - and it is very possible there will be issues in the phase III larger trials that indicate safety/efficacy issues that could delay or derail these vaccines (no mRNA vaccine has been approved to date for any infectious disease) or others. Here's the link to the Frazier interview. Let's hope he's wrong.
https://www.fiercepharma.com/vaccin...-19-vaccine-hype-a-grave-disservice-to-public
Also, here's Derek Lowe's cautiously optimistic take (In the Pipeline) on the Pfizer mRNA vaccine, which came out before Moderna's announcement this afternoon. His closing statement is worth reading...
https://blogs.sciencemag.org/pipeline/archives/2020/07/14/pfizers-progress
So good luck to Bourla and to the Pfizer/BioNTech collaboration as they push on in the clinic. Those Phase II/III trials are where all of this is going to be settled, because there is simply no other way to find out what works. Not everything will. We’re heading into an immense, unprecedented, and incredibly expensive and nerve-shredding pile-up in the clinic later this summer and fall, and I’ve said it before – we’ve never seen anything like this, and I hope we never have to again. Hold on tight.
3 mos ago, I told you mRNA would work .....:)